IGFBP3 and renal carcinoma: Aberrant DNA methylation has been shown to play an important role in the silencing of IGFBP3 expression in several human cancers, including gastric, colorectal, breast [18], ovarian [28], and renal cancer [29], as well as HCC in adults [17].